Wednesday, February 1, 2023

Novartis Stock Down On Weak Q4 Results; Sees Growth In FY23

Shares of Novartis AG were losing around 2 percent in the early morning trading in Switzerland after the drug major reported Wednesday sharply lower profit in its fourth quarter with weak sales as well as the absence of prior year's hefty Roche income. Adjusted earnings, however, topped market estimates, while top line missed their view. Further, the company announced higher dividend...

from RTT - Earnings https://ift.tt/V5gfrAD
via IFTTT

No comments:

Post a Comment